<code id='258351D2B9'></code><style id='258351D2B9'></style>
    • <acronym id='258351D2B9'></acronym>
      <center id='258351D2B9'><center id='258351D2B9'><tfoot id='258351D2B9'></tfoot></center><abbr id='258351D2B9'><dir id='258351D2B9'><tfoot id='258351D2B9'></tfoot><noframes id='258351D2B9'>

    • <optgroup id='258351D2B9'><strike id='258351D2B9'><sup id='258351D2B9'></sup></strike><code id='258351D2B9'></code></optgroup>
        1. <b id='258351D2B9'><label id='258351D2B9'><select id='258351D2B9'><dt id='258351D2B9'><span id='258351D2B9'></span></dt></select></label></b><u id='258351D2B9'></u>
          <i id='258351D2B9'><strike id='258351D2B9'><tt id='258351D2B9'><pre id='258351D2B9'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:8
          Mathai Mammen crosses his arms and looks into the camera — coverage from STAT
          FogPharma CEO Mathai Mammen Boston Globe Photo Import

          Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

          FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

          advertisement

          As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          5 important ways Henrietta Lacks changed medical science
          5 important ways Henrietta Lacks changed medical science

          HyacinthEmpinado/STATHenriettaLacks’scellshavelongbeenfamiliartoscientists—butitwastheethicalcontrov

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          NIH launches clinical trials and new research office for long Covid

          TheonlytrialunderwayrightnowwilltestwhetheralongerregimenofPfizer’santiviralPaxlovidalleviatessympto